Drug discovery could prevent spread of childhood bone cancer

(September 4, 2024)
Scientists at BC Cancer have identified a potential drug that could halt osteosarcoma’s spread.

Read about the discovery

New study explores patient preferences to improve data sharing for precision oncology across Canada

(August 13, 2024)
Results from focus groups led by BC Cancer researcher Dr. Dean Regier are guiding the development of secure data sharing platforms for precision oncology.

Read about the study

BC Cancer eliminates exam paper, saves 32 tonnes of emissions

(July 12, 2024)
The Planetary Health Unit at BC Cancer studied the waste and emissions associated with table paper use and published a peer-reviewed study in the latest edition of the B.C. Medical Journal (CBC article).

Read the Planetary Health article

Scientists discover high-risk form of endometrial cancer — and how to test for it — using AI

(July 3, 2024)
Using artificial intelligence (AI) to spot patterns across thousands of cancer cell images, the researchers have pinpointed a distinct subset of endometrial cancer that puts patients at much greater risk.

Read about the discovery

Collaboration was key to discovery about newborn immunity

(July 2, 2024)
Investigators at the BC Children’s Hospital Research Institute have made a finding that could eventually lead to therapeutic interventions for sepsis, lung disease, and other complications in premature newborns.

Read about the BCHRI study

A decade of work advances care for children with cancer

(June 11, 2024)
Researchers at BC Children’s Hospital Research Institute have been working for over a decade on a study that uses genomics to identify treatments specific to an individual child’s cancer.

Read about the genomics study

First systemic therapy patient enrolled in a clinical trial in Prince George

(May 28, 2024)
Prince George celebrated a significant milestone in early 2024: the first time that a systemic therapy clinical trial has been offered in northern B.C. to people with cancer.

Read about the systemic therapy clinical trial

Phase 2 trial finds new drug (cemdisiran) safe, potentially effective for treating IgA nephropathy

(May 13, 2024)
Dr. Sean Barbour, BC Renal Glomerulonephritis Registry's Medical Lead, partnered with international researchers to lead a small, Phase 2 clinical trial of cemdisiran.

Read about the cemdisiran trial

New study suggests Kidney Failure Risk Equation can support timely creation of vascular access points for kidney patients

(May 10, 2024)
Dr. Mohammad Atiquzzaman and colleagues from BC Renal found the Kidney Failure Risk Equation could be used to support better timing of vascular access point creation, which could lead to increased patient quality of life and improved outcomes.

Read about the Kidney Failure Risk Equation study

More research news & stories

• PHSA's Research Roadmap (September 2022)